lobbying_activities: 926417

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
926417	eb365541-24aa-45e2-b7a6-ad432bc9f271	Q1	AVENUE SOLUTIONS	72111	AETNA	2010	first_quarter	PHA	HR 1204, Community Pharmacy Fairness Act - antitrust exemption for pharmacies; HR 1427, Promoting Innovation and Access to Life Saving Medicine Act - generic biologics; HR 1548, Pathway for Biosimilars Act - generic biologics; HR 3200, America's Affordable Health Choices Act - generic biologics; HR 3590, Patient Protection and Affordable Care Act - generic biologics; HR 3962, Affordable Health Care for America Act - generic biologics; S 369, Preserve Access to Affordable Generics Act - generic drugs; S 726, Promoting Innovation and Access to Life-Saving Medicine Act - generic biologics; S 1679, Affordable Health Choices Act - generic biologics	Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2010-04-19T22:05:10.777000-04:00